Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 203 citing articles:

Ezetimibe-Loaded Nanostructured Lipid Carrier for Oral Delivery: Response Surface Methodology; In Vitro Characterization and Assessing the Antihyperlipidemic Effect in Rats
Dalia Elkhayat, Nevine Shawky Abdelmalak, Reham I. Amer, et al.
ACS Omega (2024)
Open Access | Times Cited: 7
Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
P. Barton Duell, Maciej Banach, Alberico L. Catapano, et al.
Journal of clinical lipidology (2024) Vol. 18, Iss. 2, pp. e153-e165
Open Access | Times Cited: 6
Adipocentric origin of the common cardiometabolic complications of obesity in the young up to the very old: pathophysiology and new therapeutic opportunities
Riccardo Sarzani, Matteo Landolfo, Chiara Di Pentima, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 6
Estándares SEA 2022 para el control global del riesgo cardiovascular
José María Mostaza, Xavier Pintó, Pedro Armario, et al.
Clínica e Investigación en Arteriosclerosis (2022) Vol. 34, Iss. 3, pp. 130-179
Open Access | Times Cited: 27
Very high high-density lipoprotein cholesterol may be associated with higher risk of cognitive impairment in older adults
Huifan Huang, Bin Yang, Renhe Yu, et al.
Nutrition Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles
Anne Langsted, Børge G. Nordestgaard
Clinical Chemistry (2024) Vol. 70, Iss. 7, pp. 911-933
Open Access | Times Cited: 5
Epigenetic age acceleration is associated with blood lipid levels in a multi-ancestry sample of older U.S. adults
Lisha Lin, Jenna Kiryakos, Farah Ammous, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk
Annabelle Santos Volgman, Marlys L. Koschinsky, Anurag Mehta, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 5
Role of omega-3 fatty acids in the prevention and treatment of cardiovascular Diseases: A consensus statement from the Experts’ Committee Of National Society Of Cardiometabolic Medicine
Jian‐Jun Li, Kefei Dou, Zhiguang Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Recent advances in the management and implementation of care for familial hypercholesterolaemia
N. Lan, Archna Bajaj, Gerald F. Watts, et al.
Pharmacological Research (2023) Vol. 194, pp. 106857-106857
Open Access | Times Cited: 12
Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
Pierre Gourdy, François Schiele, Jean‐Michel Halimi, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
Association of serum uric acid with risk of stroke in US adults: A cross-sectional study from NHANES 1999–2020
Bei Gao, Yun Bao, Min Meng, et al.
Journal of Stroke and Cerebrovascular Diseases (2023) Vol. 32, Iss. 8, pp. 107206-107206
Open Access | Times Cited: 11
Testing practices and clinical management of lipoprotein(a) levels: A 5-year retrospective analysis from the Johns Hopkins Hospital
Yehuda Eidensohn, Anjali Bhatla, Jie Ding, et al.
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100686-100686
Open Access | Times Cited: 4
The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis
Robert J. Sanchez, Wenzhen Ge, Wenhui Wei, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 27
Serum LDL-C/HDL-C ratio and the risk of carotid plaques: a longitudinal study
Zhuchao Wu, Xiaona Li, Qin Wen, et al.
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Inflammatory biomarkers, angiogenesis and lymphangiogenesis in epicardial adipose tissue correlate with coronary artery disease
Yueqiao Si, Zengbin Feng, Yixiang Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Lipoprotein(a): cardiovascular risk and emerging therapies
Masashi Fujino, Stephen J. Nicholls
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 4, pp. 259-268
Closed Access | Times Cited: 10
Dietary inflammation index is associated with dyslipidemia: evidence from national health and nutrition examination survey, 1999–2019
Xiaozhe Chen, Chunlei Hou, Lei Yao, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations
Nicole Ciffone, Catherine J. McNeal, Mary P. McGowan, et al.
American Heart Journal Plus Cardiology Research and Practice (2023) Vol. 38, pp. 100350-100350
Open Access | Times Cited: 10
Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank
Paul Welsh, A. Al Zabiby, Hannah Byrne, et al.
Atherosclerosis (2023) Vol. 389, pp. 117437-117437
Open Access | Times Cited: 10
Metabolic disorders after traumatic brain injury: a narrative review of systemic consequences
Amanda C. S. Kursancew, Cristiano Julio Faller, Eloa M. Piva-Uchida, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Characterization and interactions between piperine and ezetimibe in their Anti-hyperlipidemic efficacy using Biopharmaceutics and Pharmacokinetics
Kavitha Marati, Sujatha Palatheeya, Ananda Kumar Chettupalli, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Association Between Lipoprotein (a) Levels and Coronary Artery Disease (CAD) Among Patients With or Without CAD Family History
Hayato Tada, Nobuko Kojima, Kan Yamagami, et al.
Journal of Lipid and Atherosclerosis (2025) Vol. 14, Iss. 1, pp. 120-120
Open Access
Glycemic Targets and Prevention of Complications
Yumiko Tsushima, Nicholas R. Galloway
The Journal of Clinical Endocrinology & Metabolism (2025) Vol. 110, Iss. Supplement_2, pp. S100-S111
Closed Access
Lipoprotein(a) – From Biomarker to Therapy: A Review for the Clinician
Mawra Jha, Inbar R McCarthy, Eli V. Gelfand
The American Journal of Cardiology (2025)
Closed Access

Scroll to top